HIGHLIGHTS
- What: Ultimately, the authors determined that PD-L1 positive was defined as TPS ≥ 1% via previous reports in this study (Fig 2) . p16 and PD-L1 expressions were evaluated by a pathologist (N.Y.) blinded to the clinical information.
- Who: Ryo Takahashi from the Cell Carcinoma in Japan have published the research: Clinical Outcomes and Prognostic Factors of Concurrent Chemoradiotherapy for Anal Squamous Cell Carcinoma in Japan, in the Journal: (JOURNAL)
- Future: Multiinstitutional prospective studies are required to establish the treatment guidelines for locoregional ASCC in Japan.
SUMMARY
Ultimately . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.